Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

0.6100
+0.02524.31%
Post-market: 0.61000.00000.00%19:07 EDT
Volume:146.17K
Turnover:91.88K
Market Cap:8.37M
PE:-0.29
High:0.6614
Open:0.5990
Low:0.5990
Close:0.5848
52wk High:7.95
52wk Low:0.5450
Shares:13.71M
Float Shares:12.75M
Volume Ratio:0.78
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0700
EPS(LYR):-2.0700
ROE:-1599.81%
ROA:-77.74%
PB:-7.35
PE(LYR):-0.29

Loading ...

Company Profile

Company Name:
Vivos Therapeutics
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
268
Office Location:
7921 Southpark Plaza,Suite 210,Littleton,Colorado,United States
Zip Code:
80120
Fax:
- -
Introduction:
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.

Directors

Name
Position
R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer and Co-founder and Director
Anja Krammer
Director
Gregg C.E. Johnson
Director
Leonard J. Sokolow
Director
Mark F. Lindsay
Director
Matthew Thompson
Director
Ralph E. Green
Director

Shareholders

Name
Position
R. Kirk Huntsman
Chairman of the Board and Chief Executive Officer and Co-founder and Director
Bradford Amman
Chief Financial Officer